Atomoxetine hydrochloride 18mg""''""'

Oct 05, 2023

Atomoxetine hydrochloride (HCI)
ATOXETIME  is a medication primarily used in the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. ATOXETIME   is sold under the brand name Strattera.
Here are some key points about ATOXETIME  :
Indications: ATOXETIME   is indicated for the treatment of ADHD, a neurodevelopmental disorder characterized by symptoms such as hyperactivity, impulsivity, and difficulty sustaining attention. ATOXETIME   is used as part of a comprehensive treatment plan that includes psychological, educational, and social measures.
Mechanism of action: ATOXETIME   is a selective norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of norepinephrine, a neurotransmitter, in the brain. The exact mechanism by which atomoxetine improves symptoms of ADHD is not fully understood.
Effectiveness: ATOXETIME  has been shown to reduce ADHD symptoms, such as inattention, hyperactivity, and impulsivity, in clinical studies. It may take several weeks to notice the full effects of the medication, and individual responses can vary.
Side effects: Common side effects of ATOXETIME   include nausea, dry mouth, decreased appetite, insomnia, and increased heart rate or blood pressure. Some individuals may experience mood changes, dizziness, or urinary problems. In rare cases, severe allergic reactions or liver problems may occur. It is important to discuss potential side effects with a healthcare professional.
For further information please contact:
info@sterispharma.com
order now: - https://www.sterisonline.com/product/atoxetime-18-134295

SHARE WITH